- What We Do
- Who We Serve
Medacist for Pharmacies
Get the insights and analytics you need to effectively identify, evaluate and resolve any potential diversion issues across your enterprise.
We know the pain points pharmacy leaders experience on a daily basis. More importantly, we know how to solve for them.
Medacist makes it easier to manage all acting pharmacists, medication prescribers, and staff within your pharmacy. Our platform enables you to identify, evaluate, and proactively resolve any potential diversion issues, which saves you time and ensures the safety of your patients.
Be in possession of all the facts when you’re faced with any given diversion investigation. Medacist enables you to take the most logical steps towards remediation when it comes to individual actors and risks.
Through our suite of proven solutions, Medacist makes it simple to remain compliant with oversight needs. Should your team be audited, rest easy knowing you have the information needed to pass with confidence. As the saying goes, an ounce of prevention is worth a pound of cure.
Collaborate more closely and actively with your internal and external diversion teams using a workflow portal that makes communication and step-by-step processes more manageable. Medacist breaks down existing silos between your teams so that everyone is on the same page when it comes to drug diversion prevention efforts.
Had we had RxAuditor Investigate up sooner, we would have easily detected this individual at the onset.”
RxAuditor Investigate does a fantastic job of taking the top high-risk users of controlled substances in our facility and displays them in an easy to view diversion risk dashboard. To research diversion is a needle in a haystack, but with RxAuditor Investigate it brings that haystack down to a more manageable size.”
I would like to give RxAuditor Investigate credit for the “aha moment”. Our diversion team (which is multidisciplinary) was very impressed that the two most recent people we had been investigating for possible diversion were confirmed by RxAuditor Investigate. Well done!”